Hanley Jr. Michael Conick
SEC CIK 1791413 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Chief Commercial Off | 36.2K | $20.0K | — | 1 | 2022-06-08 | 2022-06-08 |
Most active insiders at SYRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir | — | $399.66M |
| 2 | Turtle Cameron | CEO, Dir | — | $9.99M |
| 3 | HENDERSON MICHAEL THOMAS | Dir | — | $7.95M |
| 4 | Sloan Sheldon | Chief Medical Off | — | $7.35M |
| 5 | Burrows Scott L | CFO | — | $6.86M |
| 6 | King-Jones Heidy | See Remarks | — | $2.48M |
| 7 | Albers Jeffrey W. | Dir | — | $2.40M |
Hanley Jr. Michael Conick made no open-market trades at SYRE in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-10 | 2022-06-08 | SYRE | Spyre Therapeutics, Inc. | Hanley Jr. Michael Conick | Chief Commercial Off | P - Purchase | $0.71 | +28.2K | 36.2K | +352% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations